Outcome of Educational Intervention on Knowledge, Attitude and Self-Efficacy of Midwives on Newborn Screening for Sickle Cell Disease in a State Hospital in Nigeria: A Pilot Study
DOI:
https://doi.org/10.25159/2520-5293/19584Keywords:
newborn screening, sickle cell disease, midwives, knowledge, self-efficacyAbstract
Background: Globally, sickle cell disease (SCD) is one of the most common genetic diseases with high childhood mortality. Newborn screening using point-of-care devices is paramount for early diagnosis and enrolment of affected children into a comprehensive care programme. The study aimed to determine the effect of educational intervention on newborn screening for SCD on midwives’ self-efficacy in State Hospital, Nigeria.
Methods: A one-group pre-/post-quasi-experimental design was used. Midwives received the educational intervention two weeks after the pretest, and the outcome was determined by comparing pre-and post-test data. Data was subjected to analysis using both descriptive and inferential statistics.
Results: Findings revealed that the midwives had a mean age of 42.6± 8.068 years, and all of them were females. Only 25% of the midwives had a high knowledge score of newborn screening at baseline, and just 45% of the midwives had a high self-efficacy in newborn screening at baseline. Paired samples t-test showed that upon completion of educational training, there was a significant difference in the knowledge and self-efficacy of newborn screening for sickle cell disease among midwives at baseline and post intervention with t=0.046, p value =0.001 and t=0.038, p value =0.000, respectively.
Conclusion: This suggests that education training on newborn screening for SCD is effective in enhancing the knowledge and self-efficacy of midwives in conducting newborn screening for SCD using point-of-care devices.
References
Aderotoye-Oni, S., I.N. Diaku-Akinwumi, A. Adeniran, and B. Falase. 2018. “Unprepared and Misinformed Parents of Children with Sickle Cell Disease: Time to Rethink Awareness Campaigns.” Cureus 10(12): e3806. DOI 10.7759/cureus.3806
Adigwe, O. P. 2023. “Access to Healthcare for People with Sickle Cell Disease: Views of Healthcare Professionals on Policies and Practices.” Molecular Genetics and Genomic Medicine 00: e2142. https://doi.org/10.1002/mgg3.2142
American Society of Hematology. 2021. “Consortium Initiates Newborn Screening Program on Sickle Cell Disease in Nigeria and Ghana.” https://www.hematology.org/newsroom/press-releases/2021/consortium-initiates-newborn-screening-program-for-sickle-cell-disease-in-nigeria-and-ghana
Coupal, E., K. Hart, B. Wong, and E. Rothwell. 2020. “Newborn Screening Knowledge and Attitudes Among Midwives and Out-of-Hospital-Birth Parents.” J Perinat Neonatal Nurs 34(4):357–364. https://doi.org/10.1097/JPN.0000000000000525
Federal Ministry of Health. 2019. “National Multi-Sectoral Action Plan for the Prevention and Control of Non-Communicable Diseases (2019–2025).” https://faolex.fao.org/docs/pdf/nig229177.pdf
GBD 2021 Sickle Cell Disease Collaborators. 2023. “Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000–2021: A Systematic Analysis from the Global Burden of Disease Study 2021.” The Lancet. Haematology 10(8): e585–e599. https://doi.org/10.1016/S2352-3026(23)00118-7
Goedert, M.H, M.P. Moeller, and K.R. White. 2011. “Midwives’ Knowledge, Attitudes, and Practices Related to Newborn Hearing Screening.” J Midwifery Women’s Health. 56(2):147–153. https://doi.org/10.1111/j.1542-2011.2011.00026.x
Jaja, C., S. Ibemere, L. Vick, J. Edem-Hotah, and R. Gibson. 2022. “Point-Of-Care Screening for Sickle Cell Disease in Rural African Community.” Healthcare Centers. HemaSphere 6(1): 56. https://doi.org/10.1111/j.1542-2011.2011.00026.x
Morfoot, C., H., and H. Stanley. 2018. “Simulation-based Education for Neonatal Skills Training and Its Impact on Self-efficacy in Post registration Nurses.” Infant 14(2): 77–81.
Nartey, E.B., J. Spector, S. Adu-Afarwuah, C.L. Jones, A. Jackson, A. Ohemeng, R. Shah, A. Koryo-Dabrah, A.B. Kuma, H.I. Hyacinth, and M. Steiner-Asiedu. 2021. “Nutritional Perspectives on Sickle Cell Disease in Africa: A Systematic Review.” BMC Nutr. 18(7)(1):9. https://doi.org/10.1186/s40795-021-00410-w
Nisselle, A., M. Bishop, T. Charles, S. Morrissy, E. King, S. Metcalfe, and C. Gaff. 2019. “Lessons Learnt from Implementing Change in Newborn Bloodspot Screening Processes Over More than a Decade: Midwives, Genetics and Education.” Midwifery 79: 102542. https://doi.org/10.1016/j.midw.102542
Nnachi, O.C., A.A. Umeokonkwo, H.C. Okoye, A.N. Ekwe, C.O. Akpa, and A.E. Okoye. 2023. “Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.” West Afr J Med 40(3):298–304. PMID: 37017939.
Nnodu, O. E., A. Sopekan, U. Nnebe-Agumadu, C. Ohiaeri, A. Adeniran, G. Shedul, A. Isa, O. Owolabi, R. Chianumba, Y. Tanko, J.H. Iyobosa, A.D. Adekile, O.I. Olopade, and F.B. Piel. 2020. “Implementing Newborn Screening for Sickle Cell Disease as Part of Immunisation Programmes in Nigeria: A Feasibility Study.” The Lancet. Haematology 7(7): e534–e540. https://doi.org/10.1016/S2352-3026(20)30143-5
Nnodu, O.E., A.P. Oron, A. Sopekan, G.O. Akaba, F.B. Piel, and D.L. Chao. 2021. “Child Mortality from Sickle Cell Disease in Nigeria: A Model-estimated, Population-level Analysis of Data from the 2018 Demographic and Health Survey.” Lancet Haematol. 8(10):e723-e731. doi: 10.1016/S2352-3026(21)00216-7
Nwabuko, O.C., U. Onwuchekwa, and O. Iheji. 2022. “An Overview of Sickle Cell Disease from the Socio-demographic Triangle - A Nigerian Single-institution Retrospective Study.” Pan Afr Med J. 23(41):161. doi: 10.11604/pamj.2022.41.161.27117
Ogbonna, C.N., O. Uwa, and I. Okechukwu. 2022. “An Overview of Sickle Cell Disease from the Socio-demographic Triangle - a Nigerian Single-institution Retrospective Study.” Pan African Medical Journal 41:161.
Oluwole, E.O., T.A. Adeyemo, G.E. Osanyin, O.O. Odukoya, P.J. Kanki, and B.B. Afolabi. 2020. “Feasibility and Acceptability of Early Infant Screening for Sickle Cell Disease in Lagos, Nigeria-A Pilot Study.” PLoS One 3(15):12:e0242861. doi: 10.1371/journal.pone.0242861
Oron, A.P., D.L. Chao, E.E. Ezeanolue, L.N. Ezenwa, F.B. Piel, O.T. Ojogun, S. Uyoga,
T.N. Williams, and O.E. Nnodu. 2020. “Caring for Africa’s Sickle Cell Children: Will We Rise to the Challenge?” BMC Med 18: 92. https://doi.org/10.1186/s12916-020-01557-2
Oyeku, S.O, H.A. Feldman, K. Ryan, S. Muret-Wagstaff, and E.J. Neufeld. 2010. “Primary Care Clinicians’ Knowledge and Confidence about Newborn Screening for Sickle Cell Disease: Randomized Assessment of Educational Strategies.” J Natl Med Assoc. 102(8):676–682. doi:10.1016/s0027-9684(15)30652-0
Padilla, P.J.D., and E.M. Manalo. 2023. “Newborn Screening Knowledge, Attitudes and Practices among Obstetrics-Gynecology Residents, Pediatric Residents, and Newborn Screening Nurses in a Tertiary Government Hospital in the Philippines during the COVID-19 Pandemic.” Int J Neonatal Screen 9(2):19. doi:10.3390/ijns9020019
Powell, C.M. 2019. “What is Newborn Screening?” N C Med J. 80(1):32–36. doi:10.18043/ncm.80.1.32
Stephen, N., N. Nden, N.J. Gusen, P.R. Kumzhi, B. Gaknung, and D.A. Auta. 2018. “Prevalence of Sickle Cell Disease among Children Attending Plateau Specialist Hospital, Jos, Nigeria.” Acta Med Int 5:20–23. doi: 10.4103/ami.ami_60_17
Zhong, A., B. Darren, B. Loiseau, He LQB, T. Chang, J. Hill, and H. Dimaras. 2021. “Ethical, Social, and Cultural Issues Related to Clinical Genetic Testing and Counselling in Low- and Middle-income Countries: A Systematic Review.” Genet Med. 23(12):2270–2280. doi:10.1038/s41436-018-0090-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Unisa PressAccepted 2026-01-09
Published 2026-03-24
